TAP Total Non-Current Liabilities

Molson Coors Beverage Company · Total Non-Current Liabilities

TAP logo

TAP Total Non-Current Liabilities

Latest reported$8.74B
TAP Quarterly Total Non-Current Liabilities ($176.90M → $8.74B)
High-resolution chart · PNG

TAP total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Molson Coors Beverage Company Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
8,738,200,000
6,878,600,000
6,884,900,000
6,859,800,000
9,789,400,000
9,612,900,000
9,566,400,000
9,819,400,000
9,742,200,000
8,851,100,000
8,847,400,000
8,842,700,000
9,702,800,000
9,627,300,000
9,577,700,000
9,720,800,000
10,270,800,000
10,395,700,000
10,332,700,000
10,341,200,000
10,391,600,000
10,733,300,000
10,800,200,000
10,589,200,000
11,565,100,000
11,511,700,000
11,491,200,000
11,456,500,000
11,836,300,000
11,733,100,000
12,073,100,000
11,957,700,000
12,382,300,000
12,392,600,000
13,412,600,000
13,724,900,000
14,504,700,000
14,683,900,000
14,562,300,000
10,650,700,000
3,782,700,000
4,069,100,000
3,996,000,000
3,959,300,000
3,416,300,000
3,412,500,000
3,784,900,000
3,791,200,000
4,776,200,000
4,669,300,000
4,774,200,000
5,166,200,000
5,186,200,000
5,531,000,000
5,593,300,000
5,462,100,000
6,068,700,000
3,528,300,000
3,456,400,000
3,205,600,000
3,069,600,000
3,505,400,000
3,521,100,000
3,269,400,000
3,219,300,000
3,338,200,000
3,347,400,000
3,059,200,000
3,253,400,000
3,022,400,000
3,440,800,000
3,848,300,000
4,174,600,000
4,143,000,000
4,522,847,000
4,605,312,000
4,324,289,000
4,201,866,000
3,939,159,000
3,930,019,000
3,885,409,000
3,873,277,000
4,154,120,000
5,123,681,000
4,112,549,000
4,098,819,000
1,842,593,000
1,807,208,000
1,900,855,000
1,976,633,000
2,085,128,000
2,119,063,000
2,205,954,000
2,133,122,000
2,167,669,000
1,966,896,000
2,012,457,000
2,012,836,000
270,835,000
226,938,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.